Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
266M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
118M
-
Shares change
-
+6.75M
-
Total reported value, excl. options
-
$970M
-
Value change
-
+$27.8M
-
Put/Call ratio
-
0.91
-
Number of buys
-
59
-
Number of sells
-
-34
-
Price
-
$8.26
Significant Holders of Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) as of Q1 2022
121 filings reported holding SANA - Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share as of Q1 2022.
Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 118M shares
of 266M outstanding shares and own 44.12% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (34.2M shares), BAILLIE GIFFORD & CO (11.1M shares), CANADA PENSION PLAN INVESTMENT BOARD (10.2M shares), FMR LLC (9.24M shares), VANGUARD GROUP INC (7.67M shares), STATE STREET CORP (7.15M shares), BlackRock Inc. (6.47M shares), Public Sector Pension Investment Board (4.13M shares), Crestline Management, LP (3.21M shares), and Alphabet Inc. (2.81M shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.